electroCore Stock Price

-0.028 (-4.13%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 208,309
Bid Price 0.642
Ask Price 0.645
News -
Day High 0.68


52 Week Range


Day Low 0.6416
Company Name Stock Ticker Symbol Market Type
electroCore Inc ECOR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.028 -4.13% 0.65 19:30:25
Open Price Low Price High Price Close Price Prev Close
0.678 0.6416 0.68 0.65625 0.678
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
693 208,309 $ 0.6655293 $ 138,636 - 0.2651 - 1.30
Last Trade Time Type Quantity Stock Price Currency
19:30:25 15 $ 0.645 USD


Draw Mode:

electroCore Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 46.23M 71.12M 65.62M $ 5.45M $ - -0.30 -2.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 408.21k 8.00%

more financials information »

electroCore News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ECOR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.65470.70030.5950.6656359678,132-0.0047-0.72%
1 Month0.590.70030.540.643724287,8720.0610.17%
3 Months0.39540.70030.370.5858654240,6810.254664.39%
6 Months0.59330.70030.26510.5227806313,6450.05679.56%
1 Year1.021.300.26510.83818451,059,912-0.37-36.27%
3 Years1.505.640.26511.601,619,204-0.85-56.67%
5 Years18.0020.250.26511.781,217,730-17.35-96.39%

electroCore Description

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients. The gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache, Bronchoconstriction and Medication Overuse Headache in adults.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now